Y-Mabs Therapeutics Inc

XNAS: YMAB

Weak Stock

Download real time

5.00 0.08 (1.63%)

71.88% Fall from 52W High

1.1M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

226.1

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Y-Mabs Therapeutics Inc - YMAB - stock price prediction, stock price target, analyst ratings from 10 analysts

Y-Mabs Therapeutics Inc has a share price target of US$ 17, revenue growth forecast of -4.7%, and profit growth estimate of -54.2% for FY25, based on top 10 analyst calls.

Forecaster Screeners